We are live on
!
Find out more
RA
RFG Advisory Portfolio holdings
AUM
$6.4B
1-Year Est. Return
19.93%
This Fund
S&P 500
This Quarter
Est. Return
+16.29%
1 Year Est. Return
+19.93%
3 Year Est. Return
+52.26%
5 Year Est. Return
+48.57%
10 Year Est. Return
+151.03%
AUM
$643M
AUM Growth
+$111M
(+21%)
Cap. Flow
+$32.1M
Cap. Flow
% of AUM
5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
419
New
69
Increased
198
Reduced
118
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$4.92M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$4.51M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$3.99M |
| 4 |
iShares US Medical Devices ETF
IHI
|
+$3.8M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.79M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.28M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.17M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$3.12M |
| 5 |
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 3.73% |
| 3 | Consumer Discretionary | 3.45% |
| 4 | Financials | 2.8% |
| 5 | Consumer Staples | 2.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $799K | 0.12% |
5,976
-33
| -0.5% | -$4.4K |
|
152
T. Rowe Price
TROW
$25B
| $797K | 0.12% |
6,453
-186
| -3% | -$21.2K |
|
153
Mastercard
MA
$477B
| $794K | 0.12% |
2,685
+185
| +7% | +$52.2K |
|
154
State Street SPDR S&P International Small Cap ETF
GWX
$861M
| $790K | 0.12% |
28,889
+8,325
| +40% | +$215K |
|
155
Iron Mountain
IRM
$38.2B
| $788K | 0.12% |
30,186
-1,380
| -4% | -$34.8K |
|
156
Vanguard Total Bond Market
BND
$157B
| $781K | 0.12% |
8,844
+1,303
| +17% | +$114K |
|
157
CVS Health
CVS
$137B
| $769K | 0.12% |
11,829
+4,837
| +69% | +$305K |
|
158
Medtronic
MDT
$107B
| $767K | 0.12% |
8,366
+864
| +12% | +$82.8K |
|
159
Bristol-Myers Squibb
BMY
$127B
| $764K | 0.12% |
12,986
+651
| +5% | +$38.9K |
|
|
STOR
160
DELISTED
STORE Capital Corporation
STOR
| $760K | 0.12% |
31,914
+27
| +0.1% | +$540 |
|
161
Netflix
NFLX
$292B
| $758K | 0.12% |
16,660
+1,050
| +7% | +$44.7K |
|
162
Thermo Fisher Scientific
TMO
$211B
| $750K | 0.12% |
2,071
+163
| +9% | +$54.6K |
|
163
W.P. Carey
WPC
$17.1B
| $744K | 0.12% |
11,232
+2,762
| +33% | +$172K |
|
164
Marathon Petroleum
MPC
$90.3B
| $730K | 0.11% |
19,518
+2,424
| +14% | +$77.9K |
|
165
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
| $716K | 0.11% |
10,313
-13,080
| -56% | -$855K |
|
166
Eaton
ETN
$157B
| $713K | 0.11% |
8,147
+13
| +0.2% | +$1.07K |
|
167
Adobe
ADBE
$89.5B
| $697K | 0.11% |
1,602
+100
| +7% | +$37.1K |
|
168
Williams-Sonoma
WSM
$26.7B
| $692K | 0.11% |
16,882
+160
| +1% | +$5.44K |
|
169
Commerce Bancshares
CBSH
$8.5B
| $689K | 0.11% |
15,522
+195
| +1% | +$8.58K |
|
170
Oneok
OKE
$58.7B
| $689K | 0.11% |
20,740
+832
| +4% | +$27.1K |
|
171
First Trust Value Line Dividend Fund
FVD
$8.29B
| $688K | 0.11% |
22,677
-29,832
| -57% | -$887K |
|
|
BSCO
172
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $686K | 0.11% |
31,132
+4,120
| +15% | +$89.1K |
|
173
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $680K | 0.11% |
7,431
+580
| +8% | +$53.1K |
|
174
Berkshire Hathaway Class B
BRK.B
$1.07T
| $664K | 0.1% |
3,717
+35
| +1% | +$6.39K |
|
175
Schwab US Large- Cap ETF
SCHX
$70.9B
| $661K | 0.1% |
53,538
+4,806
| +10% | +$56K |
|
Similar funds
PCH
BFG
EI
GT
BFS
EWM
EC
RIG
RFG Advisory's Q2 2020 Portfolio in Review
As of Q2 2020, RFG Advisory held 419 positions worth $643M, up 21% from $533M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
RFG Advisory deployed $32.1M of net new capital in Q2 2020, opening 69 new positions and adding to 198 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 88,878 shares worth $3.92M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $3.79M trimmed.
- RFG Advisory's largest Q2 2020 buy was iShares US Medical Devices ETF: 88,878 shares worth $3.92M.
- RFG Advisory added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $4.92M increase.
- RFG Advisory's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $3.79M.
- RFG Advisory fully exited First Trust Financials AlphaDEX Fund in Q2 2020, selling an estimated $1.57M.
- RFG Advisory's ten largest holdings make up 32% of its $643M portfolio in Q2 2020.
- RFG Advisory opened 69 new positions and closed 28 in Q2 2020.
- RFG Advisory's portfolio value rose 21% quarter-over-quarter to $643M.
Based on RFG Advisory's 13F filing for Q2 2020, filed 3 Aug 2020.